Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. - Wikidata - wikimedia - TriplyDB

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

http://www.wikidata.org/entity/Q30602517

about

Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma.Genomic analysis of fibrolamellar hepatocellular carcinoma.Prognostic factors in fibrolamellar hepatocellular carcinoma in young people Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.Fibrolamellar hepatocellular carcinoma: current clinical perspectives.Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma.Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection.Pediatric hepatocellular carcinoma

P2860

Q26746583-9CBD5114-C5E4-46EC-8318-61C700813758 Q27852915-CC53A11D-D4DD-473E-9B85-27B9949A1C15 Q28072292-AD95EDC0-F73C-4501-925C-8E47D98679B6 Q33591632-697695DB-FBF8-4006-846A-DB5170EE28D2 Q33652971-6A8589E2-1CD4-4967-AA71-F58BA61C2150 Q33814048-09C1742E-D336-4FD5-844E-74AA91310737 Q34673400-FF364438-3F94-48DC-8A48-939BC9D50B02 Q36023427-AF389C11-E28B-4E3C-9C02-1AC19098B654 Q36130514-CB3B138D-C7D9-4B47-8BB9-2A7FD8DE2D78 Q36268536-934816BF-43E0-477C-9217-68C96401B023 Q36731897-65563311-4285-4707-A94D-0B22C145DFEA Q37031777-31FB1F96-76B9-4735-A44B-44A807FEAF65 Q37553809-BE1D5640-A8FC-4FF4-B6D6-12CDC70000C6 Q38774463-6BCA676C-4A5D-43D4-8D91-A9E5916FD1A6 Q42928353-833C7472-8E5B-4F43-9B40-E1BDC99B010C Q47891035-BB205019-266B-45A8-9EA1-EC940D6BD422 Q52657106-4B6415EB-74D2-49D9-BAC4-B3598E635AC7 Q52689575-C75AE31B-B3EB-4D25-822F-75BED63DB4E9 Q52691238-3A8CB3EE-C917-41EB-818D-3E51A9D17D78 Q58707831-0EA6312B-C7EB-4E02-9DFE-1D4D4E1A8ECE

P2860

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

http://www.wikidata.org/entity/Q30602517

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@ast

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@en

type

label

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@ast

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@en

prefLabel

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@ast

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@en

P1433

Q30602517-DB99B384-73F7-473A-934E-26A5553E95E5

P1476

Q30602517-B4BE3783-226B-482C-A1AB-1A327E44ED66

P2093

Q30602517-0433C934-1622-4403-A1C2-1B679138D8A4

Q30602517-264E4CF7-2CA4-4818-876C-7540D96056DD

Q30602517-326DCA0A-A8A6-44C1-8DCF-F25A00FC4EE6

Q30602517-3BD37BBE-4D04-494A-AC60-A4CEEF2931B5

Q30602517-4D41E318-19F5-4762-BFF3-5F4A77D59207

Q30602517-4D4610D1-CEC3-400B-92A0-918A9642F9C8

Q30602517-5399D170-C54C-4BA6-B5C9-DA52F08AAC09

Q30602517-76ADADA9-CE10-471D-9974-1E87897E7841

Q30602517-7856E607-EBD6-4E4F-AE92-32FD13304D28

Q30602517-82FE1917-3C54-4372-B036-5AED5CF06CEE

P2860

Q30602517-20F8C7EA-BDAF-4835-B16F-8C91D5D38FE6

Q30602517-2151AABB-8FEB-46BC-A2C3-B794CDE8E45E

Q30602517-31566128-1C3B-4661-B643-0E9925F80B54

Q30602517-403348FF-B389-4D09-A5C7-FC3CCB30F4F7

Q30602517-4309A533-748B-4B0D-8EB3-7C741474CE8F

Q30602517-477981A5-D738-4F53-BE27-A0994A8C5031

Q30602517-52D1C66E-8461-42BF-ABBF-B76E29824D7F

Q30602517-5C43249C-A8B5-4950-8033-7A7C578007DD

Q30602517-63F06400-0F6E-4237-8544-246D7D7FC4CA

Q30602517-7BEAC44E-0611-4C60-BD33-FE79ADBE0E4E

P304

Q30602517-4BDE162A-BC6A-4EBE-B9FA-C9C3C59EDBE5

P31

Q30602517-976932B7-E04E-4798-93DD-7D6422A41D8C

P433

Q30602517-10C3DCC7-29E7-4805-A481-9363DFF9C17C

P478

Q30602517-E8B3A48E-8E5A-4FB5-9352-1DE9DAE2C6D1

P50

Q30602517-9FCCEF2D-9C5A-4F3E-AE79-E1142938384C

Q30602517-E7012646-C447-49A8-A17E-46DE1D17B726

P577

Q30602517-2711A0B0-DDAC-42DB-B94D-A441BFDD3AD5

P698

Q30602517-D7468A6E-9181-4852-A844-43D39A1B9C09

P932

Q30602517-6806AEB7-5A73-4459-899B-65CB63D8BFB4

P1433

Gastrointestinal cancer research : GCR

P1476

Clinicopathologic characterist ...... lamellar carcinoma consortium.

@en

P2093

Alan P Venook

http://www.w3.org/2001/XMLSchema#string

Ann Griffin

http://www.w3.org/2001/XMLSchema#string

Celina S Ang

http://www.w3.org/2001/XMLSchema#string

David Klimstra

http://www.w3.org/2001/XMLSchema#string

David P Cosgrove

http://www.w3.org/2001/XMLSchema#string

Eileen M O'Reilly

http://www.w3.org/2001/XMLSchema#string

Francesco Stipa

http://www.w3.org/2001/XMLSchema#string

Gandhi P Vallarapu

http://www.w3.org/2001/XMLSchema#string

Ghassan K Abou-Alfa

http://www.w3.org/2001/XMLSchema#string

Jennifer Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.

Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.

Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

Outcome of patients with fibrolamellar hepatocellular carcinoma.

Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.

High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma

Fibrolamellar hepatocellular carcinoma in children and adolescents.

Histologic subtypes of hepatocellular carcinoma in the southern Thai population.

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.

P304

3-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23505572

http://www.w3.org/2001/XMLSchema#string

P932

3597938

http://www.w3.org/2001/XMLSchema#string